BackMadame Bioscience Public Company Limited Overview

Madame Bioscience Public Company Limited Total Liabilities

Latest total liabilities for GLOCON.BK: $510M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$514.70M
↓ 31.95% YoYΔ $-241.64M vs prior year quarter

Peer trimmed avg / median

Loading

Madame Bioscience Public Company Limited Total Liabilities History

Loading

Madame Bioscience Public Company Limited vs. peers: Total Liabilities Comparison

Loading

Madame Bioscience Public Company Limited Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Madame Bioscience Public Company Limited (GLOCON.BK) FAQ

The latest total liabilities for GLOCON.BK is $510M as of June 2026. That compares with $760M in the prior-year period — down 31.9% year over year. Investors often review this figure alongside Madame Bioscience Public Company Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, GLOCON.BK's total liabilities moved from $760M to $510M — a 31.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Madame Bioscience Public Company Limited's operating scale or balance-sheet position.

A total liabilities figure of $510M for GLOCON.BK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GLOCON.BK's total liabilities ($510M), review year-over-year change from $760M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.